A Q and A career counselling column for students ...

Dr. Andrew Rhinehart Dr. Andrew “Andy” Rhinehart will serve as the new chief scientific and medical officer for Sansum ...

James Chalmers, MBChB, PhD, highlights the reassuring safety and tolerability profile of brensocatib in patients with non–cystic fibrosis bronchiectasis.

The biotechnology sector is entering a dynamic growth phase, fueled by advances in gene therapy, AI-assisted drug discovery, and personalized medicin ...